W.R. Berkley Corp’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-367,658
Closed -$3.82M 256
2022
Q4
$3.82M Hold
367,658
0.21% 79
2022
Q3
$3.75M Hold
367,658
0.18% 96
2022
Q2
$3.72M Hold
367,658
0.18% 99
2022
Q1
$3.71M Hold
367,658
0.19% 106
2021
Q4
$3.67M Buy
+367,658
New +$3.67M 0.2% 110

Other funds holding OCEA

W.R. Berkley Corp's OCEA Position: Q1 2023 in Review

W.R. Berkley Corp sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 367,658 shares — an estimated $3.82M sold.

W.R. Berkley Corp first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $3.82M in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • W.R. Berkley Corp reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • W.R. Berkley Corp sold 367,658 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $3.82M.
  • W.R. Berkley Corp first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • W.R. Berkley Corp's Ocean Biomedical, Inc. Common Stock position peaked at $3.82M in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on W.R. Berkley Corp's 13F filing for Q1 2023, filed 15 May 2023.